Par Drugs and Chemicals Balance Sheet
- Market cap
- ₹145 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹84.78 – ₹158.96
As of FY25, Par Drugs and Chemicals had total assets of ₹94.18 crore and borrowings of ₹17.39 crore, against shareholders' equity of ₹185 crore — a debt-to-equity ratio of 0.35.
Par Drugs and Chemicals balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 65.2 |
| Borrowings | 17.39 |
| Other liabilities | 11.59 |
| Total liabilities | 94.18 |
| Fixed assets | 50.71 |
| Capital work in progress | 45 |
| Investments | 21.73 |
| Other assets | 21.73 |
| Total assets | 94.18 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹41.32
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Par Drugs and Chemicals balance sheet — frequently asked questions
What is the total debt of Par Drugs and Chemicals?
Par Drugs and Chemicals reported borrowings of ₹17.39 crore as of FY25.
What is Par Drugs and Chemicals' debt-to-equity ratio?
Based on the FY25 balance sheet, Par Drugs and Chemicals' debt-to-equity ratio is 0.35 — borrowings of ₹17.39 crore against equity capital and reserves of ₹185 crore.
What are Par Drugs and Chemicals' total assets?
Par Drugs and Chemicals' total assets were ₹94.18 crore as of FY25, including fixed assets of ₹50.71 crore and investments of ₹21.73 crore.
What is the book value per share of Par Drugs and Chemicals?
The book value per share of Par Drugs and Chemicals is ₹41.32, based on the latest reported balance sheet.
Same Data For Peers
Trade Par Drugs and Chemicals With ATS
Track PAR live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.